Clinical Trials Sponsored by BioStata

Total 35 results

Pharmacosmos A/S
BioStata

Completed

A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency (DINO)

Anaemia in Chronic Kidney Disease

Sweden, United Kingdom
Pharmacosmos A/S
BioStata

Completed

Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)

Iron Deficiency Anemia

Denmark
Pharmacosmos A/S
BioStata

Completed

Treatment of Women After Severe Postpartum Haemorrhage (PP-02)

Severe Postpartum Haemorrhage

Denmark
Pharmacosmos A/S
BioStata

Completed

Treatment of Women After Postpartum Haemorrhage (PP-01)

Postpartum Haemorrhage

Denmark
LCA Pharmaceutical
BIOSTATEM

Completed

Assessment of Safety and Efficacy of ARTHRUM 2.5% for Treatment of Painful Osteoarthritis of the Knee (ART-ONE75)

Knee Osteoarthritis
Pharmacosmos UK Ltd
BioStata

Completed

Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)

Iron Deficiency Anaemia

United Kingdom
LCA Pharmaceutical
BIOSTATEM

Completed

Assessment of Patients Quality of Life Treated With Three ARTHRUM H 2% Joint Injections (ART-QUALIVIE)

Knee Osteoarthritis
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Recruiting

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

Solid Tumor

China
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Completed

PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer

Advanced and Metastatic Breast Cancer

China
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Suspended

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

Advanced or Metastatic CRC

China
Biostar Pharma, Inc.

Recruiting

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

Advanced Solid Tumor

United States
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Completed

Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）

Advanced Non-small Cell Lung Cancer

China
Pharmacosmos A/S
Laboratory Corporation of America; BioStata

Withdrawn

IV Iron Treatment of Restless Legs Syndrome

Restless Legs Syndrome
Medtrum France
Axonal-Biostatem

Not yet recruiting

Evaluation of Security and Efficacy of Medtrum Hybrid Closed Loop System (SEECLOOP)

Type 1 Diabetes

France
Advanced Medical Solutions Ltd.
BioStat International, Inc.

Recruiting

LiquiBand® Exceed™ and LiquiBand® Rapid™ for General Surgery Procedures (Exceed)

Surgical Wound

United States
Ferrer Internacional S.A.
Axonal-Biostatem

Completed

Clinical Trial in Children Between 3 Months and 14 Years Old to Evaluate the Efficacy and Safety of Gelatin Tannate in the Treatment of Acute Diarrhea (INDIGO) (INDIGO)

Diarrhea

Senegal
Cepheid
Axonal-Biostatem; Stève Consultants

Completed

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) (ANTICIPATE X)

Non-muscle-invasive Bladder Cancer

United Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
Pharmacosmos A/S
Laboratory Corporation of America; BioStata; ClinStar, LLC

Completed

IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose (Provide)

Iron Deficiency Anaemia

United States
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

Breast Cancer

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Completed

Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer

Breast Cancer

China
SAMEY
Axonal-Biostatem

Unknown

A Post-Authorisation Non-Interventional Observational of Patients in France With Primary Biliary Cholangitis Treated With Obeticholic Acid in Real Life (OCARELIFE)

Primary Biliary Cholangitis

France
Sun Yat-sen University
Chengdu Biostar Pharmaceuticals

Not yet recruiting

Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer

China
Laboratoires IPRAD
Creapharm; Institut Alfred Fournier; Axonal-Biostatem

Active, not recruiting

Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer. (HYDRAMUC)

Vaginal Disease

France
Maria Sklodowska-Curie National Research Institute...
Biostat Sp. z o.o.

Recruiting

Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma. (PEMBR-01)

Adrenocortical Carcinoma

Poland
Georgetown University
Riverain Medical Group, Miamisburg, OH; BioStat Solutions, Inc., Mt. Airy, MD

Completed

Reader Study of DeltaView™ Chest Radiograph Software

Lung Neoplasm

United States
Avita Medical
United States Department of Defense; Royal Perth Hospital; MedDRA Assistance Inc and other collaborators

Completed

A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries

Burns

United States
Henan Cancer Hospital
Qilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.

Not yet recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

HER-2 Negative Breast Cancer
Sun Yat-sen University
Hunan Cancer Hospital; Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer

China
Silesian Centre for Heart Diseases
Medical University of Silesia; Biostat Sp. z o.o.; Leszek Giec Upper-Silesian...

Recruiting

Cerebral Protection in Transcatheter Left Atrial Appendage Occlusion (LAAC-SBI)

Depression | Cognitive Impairment | Atrial Fibrillation | Silent Stroke

Poland
Peking University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Beijing Biostar Pharmaceuticals...

Recruiting

Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer

Esophageal Cancer

China
Assistance Publique - Hôpitaux de Paris
Imagine Institute; Axonal-Biostatem; CERBA laboratory; SATT; SNC Graft Versus Host...

Recruiting

Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft (Predictor2)

Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia in Remission | Lymphoma in Remission | Non-progressive Myeloproliferative Syndrome | Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts | Acute Leukemia Biphenotypic in Remission

France, Germany, Belgium
Zhejiang Biostar Biotechnology Co.
First Affiliated Hospital of Zhejiang University; Guangdong Provincial People... and other collaborators

Enrolling by invitation

Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)

Membranous Nephropathy - PLA2R Induced | Kidney Diseases-except Membranous Nephropathy

China
China Agricultural University
General Hospital of Chinese Armed Police Forces; Beijing Anzhen Hospital; Peking... and other collaborators

Completed

Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)

Kidney Failure, Chronic

China

Clinical Trials Sponsored by BioStata

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations